KALA (KALA BIO, Inc. Common Stock) Stock Analysis - SEC Filings

KALA BIO, Inc. Common Stock (KALA) is a publicly traded Healthcare sector company. As of May 21, 2026, KALA trades at $2.65 with a market cap of $50.38M and a P/E ratio of -0.82. KALA moved +4.35% today. Year to date, KALA is -91.40%; over the trailing twelve months it is -98.66%. Its 52-week range spans $2.52 to $1,030.00. Rallies surfaces KALA's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Where can I find KALA SEC filings?

Rallies organizes KALA SEC filing research, company disclosures, 10-K reports, 10-Q reports, and filing-driven context alongside market data, news, fundamentals, and AI research.

KALA Key Metrics

Key financial metrics for KALA
MetricValue
Price$2.65
Market Cap$50.38M
P/E Ratio-0.82
EPS$-3.31
Dividend Yield0.00%
52-Week High$1,030.00
52-Week Low$2.52
Volume0
Avg Volume0
Revenue (TTM)$0
Net Income$-26.98M
Gross Margin0.00%

Latest KALA News

Recent KALA Insider Trades

  • Iwicki Mark T sold 154.89K (~$125.46K) on Oct 23, 2025.
  • Reumuth Mary sold 967 (~$792.94) on Oct 23, 2025.
  • Reumuth Mary sold 32.23K (~$26.75K) on Oct 22, 2025.

KALA Analyst Consensus

KALA analyst coverage data. Average price target: $0.00.

Common questions about KALA

Where can I find KALA SEC filings?
Rallies organizes KALA SEC filing research, company disclosures, 10-K reports, 10-Q reports, and filing-driven context alongside market data, news, fundamentals, and AI research.
Does Rallies show KALA 10-K and 10-Q filings?
Rallies organizes KALA SEC filing research, including 10-K reports, 10-Q reports, company disclosures, and filing-driven context when available.
Is KALA research on Rallies investment advice?
No. Rallies provides research, data, and educational context for KALA. It does not provide personalized investment advice.
KALA

KALA